Pragmatic Randomized, Controlled Trial of Patient Navigators and Enhanced Personal Health Records in CKD
Sankar D. Navaneethan(Baylor College of Medicine), Joseph V. Nally(Cleveland Clinic), Susana Arrigain(Cleveland Clinic), Jesse D. Schold(Colorado School of Public Health), Barbara Tucky(Cleveland Clinic), Jennifer Hyland(Cleveland Clinic), Georges Nakhoul(Cleveland Clinic), Yvette K. Burrucker(Cleveland Clinic), Stacey E. Jolly(Cleveland Clinic), John W. Sharp(Cleveland Clinic), Victoria König(Cleveland Clinic), Priscilla Dann(Cleveland Clinic)
Cited by 56
Related Papers
Heart Disease and Stroke Statistics—2021 Update
|Circulation|2021|5.7k
K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease
|Data Archiving and Networked Services (DANS)|2003|2.5k
Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure
|JAMA|2016|696
Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies
|The Lancet Diabetes & Endocrinology|2019|330
Evaluating Glomerular Filtration Rate Slope as a Surrogate End Point for ESKD in Clinical Trials: An Individual Participant Meta-Analysis of Observational Data
|Journal of the American Society of Nephrology|2019|209